vs
Side-by-side financial comparison of Ovid Therapeutics Inc. (OVID) and Sidus Space Inc. (SIDU). Click either name above to swap in a different company.
Ovid Therapeutics Inc. is the larger business by last-quarter revenue ($718.0K vs $366.0K, roughly 2.0× Sidus Space Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs -16.2%). Over the past eight quarters, Ovid Therapeutics Inc.'s revenue compounded faster (120.3% CAGR vs -43.8%).
Sidus Space Inc is a U.S.-headquartered space technology and services provider specializing in small satellite design, manufacturing and operation. It offers end-to-end space solutions including data analytics, on-orbit servicing and custom hardware for commercial, government and academic clients worldwide, supporting various space mission objectives.
OVID vs SIDU — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $718.0K | $366.0K |
| Net Profit | — | $-11.4M |
| Gross Margin | — | -474.9% |
| Operating Margin | — | -3009.2% |
| Net Margin | — | -3115.2% |
| Revenue YoY | 844.7% | -16.2% |
| Net Profit YoY | 204.4% | -100.9% |
| EPS (diluted) | — | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $718.0K | $366.0K | ||
| Q3 25 | $132.0K | $559.1K | ||
| Q2 25 | $6.3M | $691.1K | ||
| Q1 25 | $130.0K | — | ||
| Q4 24 | $76.0K | $436.5K | ||
| Q3 24 | $173.0K | $1.8M | ||
| Q2 24 | $169.0K | $834.8K | ||
| Q1 24 | $148.0K | $845.1K |
| Q4 25 | — | $-11.4M | ||
| Q3 25 | $-12.2M | $-6.0M | ||
| Q2 25 | $-4.7M | $-5.6M | ||
| Q1 25 | $-10.2M | — | ||
| Q4 24 | — | $-5.7M | ||
| Q3 24 | $-14.0M | $-3.9M | ||
| Q2 24 | $8.5M | $-4.1M | ||
| Q1 24 | $-11.7M | $-3.8M |
| Q4 25 | — | -474.9% | ||
| Q3 25 | — | -232.3% | ||
| Q2 25 | — | -148.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -171.8% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | -100.8% | ||
| Q1 24 | — | 9.9% |
| Q4 25 | — | -3009.2% | ||
| Q3 25 | -9487.1% | -1007.2% | ||
| Q2 25 | -80.9% | -765.5% | ||
| Q1 25 | -9653.8% | — | ||
| Q4 24 | — | -1165.4% | ||
| Q3 24 | -7645.1% | -180.5% | ||
| Q2 24 | -12140.2% | -466.9% | ||
| Q1 24 | -11768.2% | -421.4% |
| Q4 25 | — | -3115.2% | ||
| Q3 25 | -9210.6% | -1079.2% | ||
| Q2 25 | -74.7% | -814.0% | ||
| Q1 25 | -7873.1% | — | ||
| Q4 24 | — | -1300.0% | ||
| Q3 24 | -8096.0% | -222.1% | ||
| Q2 24 | 5042.0% | -495.5% | ||
| Q1 24 | -7901.4% | -450.9% |
| Q4 25 | — | $-0.29 | ||
| Q3 25 | — | $-0.24 | ||
| Q2 25 | — | $-0.31 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-0.26 | ||
| Q3 24 | $-0.20 | $-0.93 | ||
| Q2 24 | $0.12 | $-0.99 | ||
| Q1 24 | $-0.17 | $-1.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.2M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $130.7M | $50.6M |
| Total Assets | $150.9M | $66.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.2M | — | ||
| Q3 25 | $20.6M | — | ||
| Q2 25 | $28.4M | — | ||
| Q1 25 | $21.1M | — | ||
| Q4 24 | $26.3M | — | ||
| Q3 24 | $15.0M | — | ||
| Q2 24 | $29.7M | — | ||
| Q1 24 | $30.8M | — |
| Q4 25 | $130.7M | $50.6M | ||
| Q3 25 | $44.7M | $24.0M | ||
| Q2 25 | $55.8M | $14.3M | ||
| Q1 25 | $59.3M | — | ||
| Q4 24 | $68.2M | $23.5M | ||
| Q3 24 | $76.3M | $9.3M | ||
| Q2 24 | $88.9M | $13.1M | ||
| Q1 24 | $78.3M | $17.2M |
| Q4 25 | $150.9M | $66.1M | ||
| Q3 25 | $63.8M | $39.9M | ||
| Q2 25 | $77.4M | $29.7M | ||
| Q1 25 | $81.7M | — | ||
| Q4 24 | $92.2M | $37.7M | ||
| Q3 24 | $102.7M | $23.1M | ||
| Q2 24 | $118.1M | $21.8M | ||
| Q1 24 | $131.6M | $25.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-38.3M | $-4.1M |
| Free Cash FlowOCF − Capex | — | $-6.5M |
| FCF MarginFCF / Revenue | — | -1768.6% |
| Capex IntensityCapex / Revenue | 0.0% | 651.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-28.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-38.3M | $-4.1M | ||
| Q3 25 | $-12.9M | $-6.2M | ||
| Q2 25 | $-4.8M | $-4.6M | ||
| Q1 25 | $-10.3M | — | ||
| Q4 24 | $-56.0M | $-5.5M | ||
| Q3 24 | $-15.0M | $-2.7M | ||
| Q2 24 | $-14.3M | $-2.2M | ||
| Q1 24 | $-16.7M | $-5.4M |
| Q4 25 | — | $-6.5M | ||
| Q3 25 | — | $-7.7M | ||
| Q2 25 | — | $-6.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-56.0M | $-7.9M | ||
| Q3 24 | $-15.0M | $-3.8M | ||
| Q2 24 | $-14.3M | $-4.0M | ||
| Q1 24 | $-16.7M | $-7.6M |
| Q4 25 | — | -1768.6% | ||
| Q3 25 | — | -1369.2% | ||
| Q2 25 | — | -870.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | -73719.7% | -1811.7% | ||
| Q3 24 | -8676.9% | -213.6% | ||
| Q2 24 | -8455.0% | -477.9% | ||
| Q1 24 | -11287.2% | -905.0% |
| Q4 25 | 0.0% | 651.5% | ||
| Q3 25 | 0.0% | 256.8% | ||
| Q2 25 | 0.0% | 199.1% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 93.4% | 543.4% | ||
| Q3 24 | 2.3% | 58.9% | ||
| Q2 24 | 20.1% | 220.1% | ||
| Q1 24 | 12.8% | 263.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.67× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
